US6090406A
(en)
*
|
1984-04-12 |
2000-07-18 |
The Liposome Company, Inc. |
Potentiation of immune responses with liposomal adjuvants
|
US5916588A
(en)
*
|
1984-04-12 |
1999-06-29 |
The Liposome Company, Inc. |
Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
|
US5192528A
(en)
*
|
1985-05-22 |
1993-03-09 |
Liposome Technology, Inc. |
Corticosteroid inhalation treatment method
|
KR950014440B1
(ko)
*
|
1986-08-11 |
1995-11-28 |
이노바타 바이오메드 리미티드 |
마이크로캡슐을 포함하는 제약학적 배합물
|
SE8603812D0
(sv)
*
|
1986-09-12 |
1986-09-12 |
Draco Ab |
Administration of liposomes to mammals
|
IE63869B1
(en)
*
|
1986-11-06 |
1995-06-14 |
Res Dev Foundation |
Aerosols containing liposomes and method for their preparation
|
US5089181A
(en)
*
|
1987-02-24 |
1992-02-18 |
Vestar, Inc. |
Method of dehydrating vesicle preparations for long term storage
|
JP2770970B2
(ja)
*
|
1987-04-09 |
1998-07-02 |
フアイソンズ・ピーエルシー |
ペンタミジンを含有する医薬組成物
|
JP2656944B2
(ja)
*
|
1987-04-30 |
1997-09-24 |
クーパー ラボラトリーズ |
タンパク質性治療剤のエアロゾール化
|
WO1989005151A1
(en)
*
|
1987-12-04 |
1989-06-15 |
The Liposome Company, Inc. |
High integrity liposomes and method of preration and use
|
WO1990009781A1
(en)
*
|
1989-02-23 |
1990-09-07 |
Rorer International (Holdings), Inc. |
Therapeutic aerosol formulations
|
US5174988A
(en)
*
|
1989-07-27 |
1992-12-29 |
Scientific Development & Research, Inc. |
Phospholipid delivery system
|
WO1991004019A1
(en)
*
|
1989-09-12 |
1991-04-04 |
The Regents Of The University Of California |
Therapeutic peptides and proteins
|
US6088613A
(en)
|
1989-12-22 |
2000-07-11 |
Imarx Pharmaceutical Corp. |
Method of magnetic resonance focused surgical and therapeutic ultrasound
|
US5585112A
(en)
*
|
1989-12-22 |
1996-12-17 |
Imarx Pharmaceutical Corp. |
Method of preparing gas and gaseous precursor-filled microspheres
|
US5733572A
(en)
*
|
1989-12-22 |
1998-03-31 |
Imarx Pharmaceutical Corp. |
Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
|
US5922304A
(en)
*
|
1989-12-22 |
1999-07-13 |
Imarx Pharmaceutical Corp. |
Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
|
US5542935A
(en)
*
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
US5705187A
(en)
*
|
1989-12-22 |
1998-01-06 |
Imarx Pharmaceutical Corp. |
Compositions of lipids and stabilizing materials
|
US5773024A
(en)
*
|
1989-12-22 |
1998-06-30 |
Imarx Pharmaceutical Corp. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
US6001335A
(en)
*
|
1989-12-22 |
1999-12-14 |
Imarx Pharmaceutical Corp. |
Contrasting agents for ultrasonic imaging and methods for preparing the same
|
US6551576B1
(en)
|
1989-12-22 |
2003-04-22 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
US6146657A
(en)
*
|
1989-12-22 |
2000-11-14 |
Imarx Pharmaceutical Corp. |
Gas-filled lipid spheres for use in diagnostic and therapeutic applications
|
US5776429A
(en)
*
|
1989-12-22 |
1998-07-07 |
Imarx Pharmaceutical Corp. |
Method of preparing gas-filled microspheres using a lyophilized lipids
|
US5469854A
(en)
*
|
1989-12-22 |
1995-11-28 |
Imarx Pharmaceutical Corp. |
Methods of preparing gas-filled liposomes
|
US5352435A
(en)
*
|
1989-12-22 |
1994-10-04 |
Unger Evan C |
Ionophore containing liposomes for ultrasound imaging
|
US5305757A
(en)
*
|
1989-12-22 |
1994-04-26 |
Unger Evan C |
Gas filled liposomes and their use as ultrasonic contrast agents
|
US20020150539A1
(en)
*
|
1989-12-22 |
2002-10-17 |
Unger Evan C. |
Ultrasound imaging and treatment
|
US5580575A
(en)
*
|
1989-12-22 |
1996-12-03 |
Imarx Pharmaceutical Corp. |
Therapeutic drug delivery systems
|
US5656211A
(en)
*
|
1989-12-22 |
1997-08-12 |
Imarx Pharmaceutical Corp. |
Apparatus and method for making gas-filled vesicles of optimal size
|
GB9001019D0
(en)
*
|
1990-01-17 |
1990-03-14 |
Euro Celtique Sa |
Pharmaceutical aerosol
|
US5162361A
(en)
*
|
1990-04-10 |
1992-11-10 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Method of treating diseases associated with elevated levels of interleukin 1
|
US5370862A
(en)
*
|
1990-06-13 |
1994-12-06 |
Schwarz Pharma Ag |
Pharmaceutical hydrophilic spray containing nitroglycerin for treating angina
|
US5258289A
(en)
*
|
1990-09-05 |
1993-11-02 |
Davis Claude G |
Method for the selecting of genes encoding catalytic antibodies
|
US5874062A
(en)
*
|
1991-04-05 |
1999-02-23 |
Imarx Pharmaceutical Corp. |
Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
|
US5205290A
(en)
|
1991-04-05 |
1993-04-27 |
Unger Evan C |
Low density microspheres and their use as contrast agents for computed tomography
|
US5993805A
(en)
*
|
1991-04-10 |
1999-11-30 |
Quadrant Healthcare (Uk) Limited |
Spray-dried microparticles and their use as therapeutic vehicles
|
US5683714A
(en)
*
|
1991-04-19 |
1997-11-04 |
Nexstar Pharmaceuticals, Inc. |
Liposomal cyclosporin pharmaceutical formulation
|
US5457100A
(en)
*
|
1991-12-02 |
1995-10-10 |
Daniel; David G. |
Method for treatment of recurrent paroxysmal neuropsychiatric
|
US5639441A
(en)
*
|
1992-03-06 |
1997-06-17 |
Board Of Regents Of University Of Colorado |
Methods for fine particle formation
|
US5814666A
(en)
*
|
1992-04-13 |
1998-09-29 |
The United States As Represented By The Department Of Health And Human Services |
Encapsulated and non-encapsulated nitric oxide generators used as antimicrobial agents
|
US6582728B1
(en)
*
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
US6673335B1
(en)
*
|
1992-07-08 |
2004-01-06 |
Nektar Therapeutics |
Compositions and methods for the pulmonary delivery of aerosolized medicaments
|
US5350359A
(en)
*
|
1992-07-16 |
1994-09-27 |
Temple University Of The Commonwealth System Of Higher Education |
Control, treatment and/or diagnosis of physiological conditions with degassed perfluorocarbon liquid
|
ATE220327T1
(de)
*
|
1992-09-29 |
2002-07-15 |
Inhale Therapeutic Syst |
Pulmonale abgabe von aktiven fragmenten des parathormons
|
ATE168497T1
(de)
*
|
1993-01-21 |
1998-08-15 |
Mayo Foundation |
Mikropartikelschaltvorrichtung
|
US7448375B2
(en)
*
|
1993-01-29 |
2008-11-11 |
Aradigm Corporation |
Method of treating diabetes mellitus in a patient
|
US6024090A
(en)
*
|
1993-01-29 |
2000-02-15 |
Aradigm Corporation |
Method of treating a diabetic patient by aerosolized administration of insulin lispro
|
US5441060A
(en)
*
|
1993-02-08 |
1995-08-15 |
Duke University |
Dry powder delivery system
|
US5654006A
(en)
*
|
1993-02-12 |
1997-08-05 |
Mayo Foundation For Medical Education And Research |
Condensed-phase microparticle composition and method
|
US5593661A
(en)
*
|
1993-03-29 |
1997-01-14 |
Henry; Richard A. |
Lidocaine aerosol anaesthetic
|
AU732440B2
(en)
*
|
1993-06-11 |
2001-04-26 |
Imarx Pharmaceutical Corp. |
Novel therapeutic delivery systems
|
US6794357B1
(en)
*
|
1993-06-24 |
2004-09-21 |
Astrazeneca Ab |
Compositions for inhalation
|
US5830853A
(en)
*
|
1994-06-23 |
1998-11-03 |
Astra Aktiebolag |
Systemic administration of a therapeutic preparation
|
TW402506B
(en)
|
1993-06-24 |
2000-08-21 |
Astra Ab |
Therapeutic preparation for inhalation
|
US20010003739A1
(en)
*
|
1993-06-24 |
2001-06-14 |
Astrazeneca Ab |
Systemic administration of a therapeutic preparation
|
US6632456B1
(en)
|
1993-06-24 |
2003-10-14 |
Astrazeneca Ab |
Compositions for inhalation
|
US5747445A
(en)
*
|
1993-06-24 |
1998-05-05 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
IS1796B
(is)
*
|
1993-06-24 |
2001-12-31 |
Ab Astra |
Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
|
JPH08512056A
(ja)
*
|
1993-06-30 |
1996-12-17 |
ジェネンテク・インコーポレイテッド |
リポソームの製造法
|
WO1995009612A1
(en)
*
|
1993-10-07 |
1995-04-13 |
Entremed, Inc. |
Encapsulated and non-encapsulated nitric oxide generators used as antimicrobial agents
|
US6127356A
(en)
|
1993-10-15 |
2000-10-03 |
Duke University |
Oxidant scavengers
|
US5994339A
(en)
*
|
1993-10-15 |
1999-11-30 |
University Of Alabama At Birmingham Research Foundation |
Oxidant scavengers
|
US5747026A
(en)
*
|
1993-10-15 |
1998-05-05 |
University Of Alabama At Birmingham Research Foundation |
Antioxidants
|
US7083572B2
(en)
*
|
1993-11-30 |
2006-08-01 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Therapeutic delivery systems
|
DE4402867C1
(de)
*
|
1994-01-31 |
1995-06-14 |
Rentschler Arzneimittel |
Liposomen enthaltend darin verkapselte Proteine, Verfahren zu ihrer Herstellung sowie diese Liposomen enthaltende pharmazeutische und kosmetische Zubereitungen
|
US6773719B2
(en)
|
1994-03-04 |
2004-08-10 |
Esperion Luv Development, Inc. |
Liposomal compositions, and methods of using liposomal compositions to treat dislipidemias
|
US6312719B1
(en)
*
|
1994-03-04 |
2001-11-06 |
The University Of British Columbia |
Liposome compositions and methods for the treatment of atherosclerosis
|
EP0748213B1
(de)
|
1994-03-07 |
2004-04-14 |
Nektar Therapeutics |
Verfahren und mittel zur verabreichung von insulin über die lunge
|
US6102036A
(en)
*
|
1994-04-12 |
2000-08-15 |
Smoke-Stop |
Breath activated inhaler
|
US5451569A
(en)
*
|
1994-04-19 |
1995-09-19 |
Hong Kong University Of Science And Technology R & D Corporation Limited |
Pulmonary drug delivery system
|
ATE299892T1
(de)
|
1994-05-18 |
2005-08-15 |
Nektar Therapeutics |
Methoden und zusammensetzungen für die trockenpuderarznei aus interferonen
|
US5736121A
(en)
*
|
1994-05-23 |
1998-04-07 |
Imarx Pharmaceutical Corp. |
Stabilized homogenous suspensions as computed tomography contrast agents
|
US6165976A
(en)
|
1994-06-23 |
2000-12-26 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
WO1996009053A1
(en)
*
|
1994-09-20 |
1996-03-28 |
Duke University |
Oxidoreductase activity of manganic porphyrins
|
US6743779B1
(en)
|
1994-11-29 |
2004-06-01 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
PL320856A1
(en)
|
1994-12-22 |
1997-11-10 |
Astra Ab |
Aerosol drug preparations
|
EE9700136A
(et)
|
1994-12-22 |
1997-12-15 |
Astra Aktiebolag |
Paratüroidhormooni PTH sisaldav ravimpreparaat inhaleerimiseks
|
US6524557B1
(en)
|
1994-12-22 |
2003-02-25 |
Astrazeneca Ab |
Aerosol formulations of peptides and proteins
|
SE9404468D0
(sv)
*
|
1994-12-22 |
1994-12-22 |
Astra Ab |
Powder formulations
|
US5854202A
(en)
*
|
1995-01-24 |
1998-12-29 |
Dedhar; Shoukat |
Peptide fragments of calreticulin, peptide mimetics thereof, and pharmaceutical compostions comprising same
|
US6518397B1
(en)
|
1997-07-24 |
2003-02-11 |
Shoukat Dedhar |
Pharmaceuticals for modulating hormone responsiveness
|
US5830430A
(en)
*
|
1995-02-21 |
1998-11-03 |
Imarx Pharmaceutical Corp. |
Cationic lipids and the use thereof
|
JPH10510198A
(ja)
*
|
1995-05-12 |
1998-10-06 |
ジェネンテク・インコーポレイテッド |
機能生物学的物質の粗いスプレー供給
|
US5997898A
(en)
*
|
1995-06-06 |
1999-12-07 |
Imarx Pharmaceutical Corp. |
Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
|
US6033645A
(en)
*
|
1996-06-19 |
2000-03-07 |
Unger; Evan C. |
Methods for diagnostic imaging by regulating the administration rate of a contrast agent
|
US6231834B1
(en)
|
1995-06-07 |
2001-05-15 |
Imarx Pharmaceutical Corp. |
Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
|
US5693336A
(en)
*
|
1995-06-07 |
1997-12-02 |
Nexstar Pharmaceuticals, Inc. |
Blood stable liposomal cyclosporin formulations
|
US6521211B1
(en)
*
|
1995-06-07 |
2003-02-18 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Methods of imaging and treatment with targeted compositions
|
US6139819A
(en)
*
|
1995-06-07 |
2000-10-31 |
Imarx Pharmaceutical Corp. |
Targeted contrast agents for diagnostic and therapeutic use
|
US5603918A
(en)
*
|
1995-06-09 |
1997-02-18 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aerosol composition of a salt of ipratropium and a salt of albuterol
|
WO1997040679A1
(en)
|
1996-05-01 |
1997-11-06 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
US6652837B1
(en)
|
1996-05-24 |
2003-11-25 |
Massachusetts Institute Of Technology |
Preparation of novel particles for inhalation
|
US20020052310A1
(en)
*
|
1997-09-15 |
2002-05-02 |
Massachusetts Institute Of Technology The Penn State Research Foundation |
Particles for inhalation having sustained release properties
|
GB9615350D0
(en)
*
|
1996-07-22 |
1996-09-04 |
Resource Medical Limited |
Hormone replacement therapy
|
GB9616237D0
(en)
*
|
1996-08-01 |
1996-09-11 |
Norton Healthcare Ltd |
Aerosol formulations
|
US6414139B1
(en)
|
1996-09-03 |
2002-07-02 |
Imarx Therapeutics, Inc. |
Silicon amphiphilic compounds and the use thereof
|
CA2263568C
(en)
*
|
1996-09-11 |
2008-12-02 |
Imarx Pharmaceutical Corp. |
Methods for diagnostic imaging using a contrast agent and a renal vasodilator
|
US5846517A
(en)
*
|
1996-09-11 |
1998-12-08 |
Imarx Pharmaceutical Corp. |
Methods for diagnostic imaging using a renal contrast agent and a vasodilator
|
US6056973A
(en)
|
1996-10-11 |
2000-05-02 |
Sequus Pharmaceuticals, Inc. |
Therapeutic liposome composition and method of preparation
|
AU741439B2
(en)
*
|
1996-12-30 |
2001-11-29 |
Battelle Memorial Institute |
Formulation and method for treating neoplasms by inhalation
|
US6120751A
(en)
|
1997-03-21 |
2000-09-19 |
Imarx Pharmaceutical Corp. |
Charged lipids and uses for the same
|
US6537246B1
(en)
|
1997-06-18 |
2003-03-25 |
Imarx Therapeutics, Inc. |
Oxygen delivery agents and uses for the same
|
US6090800A
(en)
*
|
1997-05-06 |
2000-07-18 |
Imarx Pharmaceutical Corp. |
Lipid soluble steroid prodrugs
|
US6143276A
(en)
*
|
1997-03-21 |
2000-11-07 |
Imarx Pharmaceutical Corp. |
Methods for delivering bioactive agents to regions of elevated temperatures
|
US20050019266A1
(en)
*
|
1997-05-06 |
2005-01-27 |
Unger Evan C. |
Novel targeted compositions for diagnostic and therapeutic use
|
US7452551B1
(en)
|
2000-10-30 |
2008-11-18 |
Imarx Therapeutics, Inc. |
Targeted compositions for diagnostic and therapeutic use
|
US6416740B1
(en)
|
1997-05-13 |
2002-07-09 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Acoustically active drug delivery systems
|
US20020039594A1
(en)
*
|
1997-05-13 |
2002-04-04 |
Evan C. Unger |
Solid porous matrices and methods of making and using the same
|
US20030035778A1
(en)
*
|
1997-07-14 |
2003-02-20 |
Robert Platz |
Methods and compositions for the dry powder formulation of interferon
|
US7179615B1
(en)
*
|
1997-07-29 |
2007-02-20 |
Menzies School Of Health Research |
Method of prophylaxis and treatment
|
US6548047B1
(en)
|
1997-09-15 |
2003-04-15 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Thermal preactivation of gaseous precursor filled compositions
|
US7052678B2
(en)
|
1997-09-15 |
2006-05-30 |
Massachusetts Institute Of Technology |
Particles for inhalation having sustained release properties
|
ATE248583T1
(de)
*
|
1997-09-29 |
2003-09-15 |
Nektar Therapeutics |
In dosierinhalatoren verwendbare, stabilisierte zubereitungen
|
JP2001521939A
(ja)
|
1997-11-03 |
2001-11-13 |
デューク・ユニバーシティー |
置換されたポルフィリン類
|
WO1999024016A1
(en)
*
|
1997-11-10 |
1999-05-20 |
Sonus Pharmaceuticals, Inc. |
Emulsions for aerosolization and drug delivery
|
EP1082108B1
(de)
*
|
1997-12-03 |
2002-12-18 |
Britannia Pharmaceuticals Limited |
Verwendung von phospholipiden zur herstellung eines arzneimittels zur behandlung von asthma
|
US6123923A
(en)
*
|
1997-12-18 |
2000-09-26 |
Imarx Pharmaceutical Corp. |
Optoacoustic contrast agents and methods for their use
|
US20010003580A1
(en)
|
1998-01-14 |
2001-06-14 |
Poh K. Hui |
Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
|
ATE311206T1
(de)
|
1998-04-24 |
2005-12-15 |
Univ Duke |
Substituierte porphyrine
|
US6956021B1
(en)
*
|
1998-08-25 |
2005-10-18 |
Advanced Inhalation Research, Inc. |
Stable spray-dried protein formulations
|
US6703384B2
(en)
*
|
1998-09-23 |
2004-03-09 |
Research Development Foundation |
Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
|
US8933032B2
(en)
|
1998-10-20 |
2015-01-13 |
Children's Hospital Medical Center |
Surfactant protein D for the treatment of disorders associated with lung injury
|
ES2281199T3
(es)
*
|
1998-11-12 |
2007-09-16 |
Transave, Inc. |
Sistema de inhalacion.
|
EP1839648A3
(de)
*
|
1998-11-12 |
2007-11-21 |
Transave, Inc. |
Inhalationssystem
|
GB9912639D0
(en)
*
|
1999-05-28 |
1999-07-28 |
Britannia Pharmaceuticals Ltd |
Improvements in and relating to treatment of respiratory conditions
|
EP1616869B1
(de)
*
|
1999-01-25 |
2012-04-04 |
National Jewish Health |
Substituierte Porphyrine und deren therapeutische Verwendung
|
US20050196345A1
(en)
*
|
1999-02-03 |
2005-09-08 |
Max-Delbruck-Centrum Fur Molekulare Medizin |
Compressed air inhaler for pulmonary application of liposomal powder aerosols and powder aerosols
|
JP2002538855A
(ja)
|
1999-02-03 |
2002-11-19 |
マックス−デルブルック−セントラム フュール モレクラーレ メディツィン |
リポソーム粉末エアロゾルの肺適用のための圧縮空気吸入器及びそのために適した粉末エアロゾル
|
US6521212B1
(en)
*
|
1999-03-18 |
2003-02-18 |
United Therapeutics Corporation |
Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation
|
US6613352B2
(en)
|
1999-04-13 |
2003-09-02 |
Universite De Montreal |
Low-rigidity liposomal formulation
|
US7258850B2
(en)
*
|
1999-05-04 |
2007-08-21 |
Aradigm Corporation |
Methods and compositions for treating erectile dysfunction
|
CA2373681A1
(en)
*
|
1999-05-14 |
2000-11-23 |
Dennis I. Goldberg |
Pharmaceutical compositions for treating angina and/or anginal equivalents, and kit relating thereto
|
JP2003501376A
(ja)
*
|
1999-06-04 |
2003-01-14 |
スカイファーマ インコーポレーテッド |
疎水性薬物の持続性放出のための油コア組成物
|
DE60019920T2
(de)
|
1999-06-05 |
2006-02-23 |
Innovata Biomed Ltd., St. Albans |
Verabreichungsystem für medikamente
|
US6749835B1
(en)
|
1999-08-25 |
2004-06-15 |
Advanced Inhalation Research, Inc. |
Formulation for spray-drying large porous particles
|
US20010036481A1
(en)
*
|
1999-08-25 |
2001-11-01 |
Advanced Inhalation Research, Inc. |
Modulation of release from dry powder formulations
|
WO2001013891A2
(en)
*
|
1999-08-25 |
2001-03-01 |
Advanced Inhalation Research, Inc. |
Modulation of release from dry powder formulations
|
US7678364B2
(en)
|
1999-08-25 |
2010-03-16 |
Alkermes, Inc. |
Particles for inhalation having sustained release properties
|
GB9920839D0
(en)
|
1999-09-04 |
1999-11-10 |
Innovata Biomed Ltd |
Inhaler
|
US6156294A
(en)
*
|
1999-11-28 |
2000-12-05 |
Scientific Development And Research, Inc. |
Composition and method for treatment of otitis media
|
US6676930B2
(en)
|
1999-11-28 |
2004-01-13 |
Scientific Development And Research, Inc. |
Composition and method for treatment of otitis media
|
US6761909B1
(en)
|
1999-12-21 |
2004-07-13 |
Rxkinetix, Inc. |
Particulate insulin-containing products and method of manufacture
|
AU2729101A
(en)
*
|
1999-12-21 |
2001-07-03 |
Rxkinetix, Inc. |
Particulate drug-containing products and method of manufacture
|
ATE382615T1
(de)
*
|
2000-02-11 |
2008-01-15 |
Res Dev Foundation |
Tocopherole, tocotrienole, andere chrome und seitenketten-derivate und ihre verwendung
|
US8404217B2
(en)
*
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
US20020106368A1
(en)
*
|
2000-07-28 |
2002-08-08 |
Adrian Bot |
Novel methods and compositions to upregulate, redirect or limit immune responses to peptides, proteins and other bioactive compounds and vectors expressing the same
|
US6613308B2
(en)
*
|
2000-09-19 |
2003-09-02 |
Advanced Inhalation Research, Inc. |
Pulmonary delivery in treating disorders of the central nervous system
|
US6514482B1
(en)
|
2000-09-19 |
2003-02-04 |
Advanced Inhalation Research, Inc. |
Pulmonary delivery in treating disorders of the central nervous system
|
WO2002054868A2
(en)
|
2000-12-21 |
2002-07-18 |
Inhale Therapeutic Syst |
Pulmonary delivery of polyene antifungal agents
|
US20020141946A1
(en)
*
|
2000-12-29 |
2002-10-03 |
Advanced Inhalation Research, Inc. |
Particles for inhalation having rapid release properties
|
ATE439134T1
(de)
*
|
2001-01-19 |
2009-08-15 |
Nat Jewish Med & Res Center |
Medikament zum schutz in der radiotherapie
|
GB0102902D0
(en)
*
|
2001-02-06 |
2001-03-21 |
Innovata Biomed Ltd |
Medicaments
|
CA2435982C
(en)
*
|
2001-02-06 |
2014-05-06 |
Innovata Biomed Limited |
Medicaments
|
NZ529417A
(en)
*
|
2001-05-24 |
2006-11-30 |
Alexza Pharmaceuticals Inc |
Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
|
JP2005503425A
(ja)
*
|
2001-05-24 |
2005-02-03 |
アレックザ モレキュラー デリヴァリー コーポレイション |
所定の吸入ルートによる薬剤エステルの送出
|
US7090830B2
(en)
|
2001-05-24 |
2006-08-15 |
Alexza Pharmaceuticals, Inc. |
Drug condensation aerosols and kits
|
US20070122353A1
(en)
|
2001-05-24 |
2007-05-31 |
Hale Ron L |
Drug condensation aerosols and kits
|
WO2002094240A1
(en)
*
|
2001-05-24 |
2002-11-28 |
Alexza Molecular Delivery Corporation |
Delivery of physiologically active compounds through an inhalation route
|
US7458374B2
(en)
|
2002-05-13 |
2008-12-02 |
Alexza Pharmaceuticals, Inc. |
Method and apparatus for vaporizing a compound
|
US20030051728A1
(en)
*
|
2001-06-05 |
2003-03-20 |
Lloyd Peter M. |
Method and device for delivering a physiologically active compound
|
US7645442B2
(en)
|
2001-05-24 |
2010-01-12 |
Alexza Pharmaceuticals, Inc. |
Rapid-heating drug delivery article and method of use
|
US7498019B2
(en)
|
2001-05-24 |
2009-03-03 |
Alexza Pharmaceuticals, Inc. |
Delivery of compounds for the treatment of headache through an inhalation route
|
WO2002094242A1
(en)
*
|
2001-05-24 |
2002-11-28 |
Alexza Molecular Delivery Corporation |
Delivery of rizatriptan or zolmitriptan through an inhalation route
|
AU2002312194B8
(en)
*
|
2001-06-01 |
2008-05-15 |
Aeolus Sciences, Inc. |
Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance
|
US7125568B2
(en)
*
|
2001-08-23 |
2006-10-24 |
Sung Michael T |
Lipophilic drug compositions
|
PL369545A1
(en)
*
|
2001-09-28 |
2005-05-02 |
Esperion Therapeutics, Inc. |
Methods and apparatus for extrusion of vesicles at high pressure
|
WO2003041693A1
(en)
*
|
2001-11-09 |
2003-05-22 |
Alexza Molecular Delivery Corporation |
Delivery of diazepam through an inhalation route
|
US20050118250A1
(en)
*
|
2001-11-13 |
2005-06-02 |
Paul Tardi |
Lipid carrier compositions with enhanced blood stability
|
CA2465675C
(en)
*
|
2001-11-20 |
2008-06-10 |
Advanced Inhalation Research, Inc. |
Improved particulate compositions for pulmonary delivery
|
WO2003043603A1
(en)
*
|
2001-11-20 |
2003-05-30 |
Advanced Inhalation Research, Inc. |
Particulate compositions for improving solubility of poorly soluble agents
|
WO2003057188A1
(en)
|
2001-11-21 |
2003-07-17 |
Alexza Molecular Delivery Corporation |
Delivery of caffeine through an inhalation route
|
GB0128148D0
(en)
*
|
2001-11-23 |
2002-01-16 |
Innovata Biomed Ltd |
Assembly
|
US20030236301A1
(en)
*
|
2001-12-19 |
2003-12-25 |
Bob Sanders |
Liposomal delivery of vitamin E based compounds
|
CN100515497C
(zh)
*
|
2001-12-19 |
2009-07-22 |
研究发展基金会 |
脂质体输送以维生素e为基础的化合物
|
WO2003075977A2
(en)
*
|
2002-03-05 |
2003-09-18 |
Cleveland State University |
Agglomerated particles for aerosol drug delivery
|
AU2003230600B2
(en)
*
|
2002-03-05 |
2009-06-04 |
Transave, Inc. |
An inhalation system for prevention and treatment of intracellular infections
|
ES2609482T3
(es)
|
2002-03-20 |
2017-04-20 |
Civitas Therapeutics, Inc. |
Administración pulmonar de levodopa
|
DE10214983A1
(de)
|
2002-04-04 |
2004-04-08 |
TransMIT Gesellschaft für Technologietransfer mbH |
Vernebelbare Liposomen und ihre Verwendung zur pulmonalen Applikation von Wirkstoffen
|
US20040009216A1
(en)
*
|
2002-04-05 |
2004-01-15 |
Rodrigueza Wendi V. |
Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
|
WO2003094900A1
(en)
|
2002-05-13 |
2003-11-20 |
Alexza Molecular Delivery Corporation |
Delivery of drug amines through an inhalation route
|
US20060193788A1
(en)
*
|
2002-11-26 |
2006-08-31 |
Hale Ron L |
Acute treatment of headache with phenothiazine antipsychotics
|
US6930137B2
(en)
*
|
2002-05-31 |
2005-08-16 |
Fina Technology, Inc. |
Method of improving blown film processing performance and physical properties
|
AU2003237500A1
(en)
*
|
2002-06-07 |
2003-12-22 |
Duke University |
Substituted porphyrins
|
US20040213837A1
(en)
*
|
2002-08-05 |
2004-10-28 |
Sankaram Mantripragada |
Oil-core compositions for the sustained release of hydrophobic drugs
|
US7879351B2
(en)
|
2002-10-29 |
2011-02-01 |
Transave, Inc. |
High delivery rates for lipid based drug formulations, and methods of treatment thereof
|
KR101301653B1
(ko)
|
2002-10-29 |
2013-08-30 |
트랜세이브, 인코포레이티드 |
항감염제의 지속적인 방출
|
US7718189B2
(en)
|
2002-10-29 |
2010-05-18 |
Transave, Inc. |
Sustained release of antiinfectives
|
US20040105818A1
(en)
*
|
2002-11-26 |
2004-06-03 |
Alexza Molecular Delivery Corporation |
Diuretic aerosols and methods of making and using them
|
CN101371843B
(zh)
*
|
2002-11-26 |
2012-09-26 |
艾利斯达医药品公司 |
洛沙平和阿莫沙平在制备治疗疼痛的药物中的应用
|
CA2507158A1
(en)
*
|
2002-11-26 |
2004-06-10 |
Alexza Molecular Delivery Corporation |
Treatment of headache with antipsychotics delivered by inhalation
|
US7550133B2
(en)
*
|
2002-11-26 |
2009-06-23 |
Alexza Pharmaceuticals, Inc. |
Respiratory drug condensation aerosols and methods of making and using them
|
US7913688B2
(en)
*
|
2002-11-27 |
2011-03-29 |
Alexza Pharmaceuticals, Inc. |
Inhalation device for producing a drug aerosol
|
ES2370395T3
(es)
|
2003-05-21 |
2011-12-15 |
Alexza Pharmaceuticals, Inc. |
Utilización de una capa de combustible sólido, procedimiento para fabricarla y unidad de calefacción correspondiente.
|
KR20060015265A
(ko)
*
|
2003-05-30 |
2006-02-16 |
알자 코포레이션 |
제제의 폐 투여 방법
|
US20090124697A1
(en)
|
2003-12-16 |
2009-05-14 |
United Therapeutics Corporation |
Inhalation formulations of treprostinil
|
ATE473736T1
(de)
*
|
2003-12-16 |
2010-07-15 |
United Therapeutics Corp |
Verwendung von treprostinil zur behandlung von ischämischen läsionen
|
US7994225B2
(en)
*
|
2004-03-17 |
2011-08-09 |
Rempex Pharmaceuticals, Inc. |
Bacterial efflux pump inhibitors for the treatment of ophthalmic and otic infections
|
EP1732527A2
(de)
*
|
2004-03-17 |
2006-12-20 |
Mpex Pharmaceuticals, Inc. |
Verwendung und verabreichung von bakteriellen ausfluss-pumpenhemmern
|
WO2005102429A1
(en)
*
|
2004-04-21 |
2005-11-03 |
Innovata Biomed Limited |
Inhaler
|
GB0409197D0
(en)
|
2004-04-24 |
2004-05-26 |
Innovata Biomed Ltd |
Device
|
US7540286B2
(en)
*
|
2004-06-03 |
2009-06-02 |
Alexza Pharmaceuticals, Inc. |
Multiple dose condensation aerosol devices and methods of forming condensation aerosols
|
US20060051406A1
(en)
*
|
2004-07-23 |
2006-03-09 |
Manjeet Parmar |
Formulation of insoluble small molecule therapeutics in lipid-based carriers
|
US20100006092A1
(en)
*
|
2004-08-12 |
2010-01-14 |
Alexza Pharmaceuticals, Inc. |
Aerosol Drug Delivery Device Incorporating Percussively Activated Heat Packages
|
CA2576961A1
(en)
*
|
2004-08-12 |
2006-03-02 |
Alexza Pharmaceuticals, Inc. |
Aerosol drug delivery device incorporating percussively activated heat packages
|
US8337815B2
(en)
*
|
2004-12-23 |
2012-12-25 |
Discovery Laboratories, Inc. |
Pulmonary surfactant formulations
|
US20070031342A1
(en)
*
|
2005-06-22 |
2007-02-08 |
Nektar Therapeutics |
Sustained release microparticles for pulmonary delivery
|
CA2620364A1
(en)
|
2005-08-26 |
2007-03-01 |
David C. Yeomans |
Methods for treatment of headaches by administration of oxytocin
|
US8246984B2
(en)
*
|
2005-12-06 |
2012-08-21 |
Rigel Pharmaceuticals, Inc. |
Formulation of insoluble small molecule therapeutics in lipid-based carriers
|
EP3067047B1
(de)
|
2005-12-08 |
2022-04-20 |
Insmed Incorporated |
Antiinfektive zusammensetzungen auf lipidbasis zur behandlung von lungeninfekten
|
KR100795221B1
(ko)
|
2006-05-19 |
2008-01-17 |
한국화학연구원 |
암포테리신 β를 봉입하고 표면이 헤파린으로 수식된리포솜 및 그 제조 방법
|
US20070286814A1
(en)
*
|
2006-06-12 |
2007-12-13 |
Medispray Laboratories Pvt. Ltd. |
Stable aerosol pharmaceutical formulations
|
WO2008112661A2
(en)
|
2007-03-09 |
2008-09-18 |
Alexza Pharmaceuticals, Inc. |
Heating unit for use in a drug delivery device
|
WO2008137717A1
(en)
|
2007-05-04 |
2008-11-13 |
Transave, Inc. |
Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof
|
US9119783B2
(en)
|
2007-05-07 |
2015-09-01 |
Insmed Incorporated |
Method of treating pulmonary disorders with liposomal amikacin formulations
|
US9333214B2
(en)
|
2007-05-07 |
2016-05-10 |
Insmed Incorporated |
Method for treating pulmonary disorders with liposomal amikacin formulations
|
US9114081B2
(en)
|
2007-05-07 |
2015-08-25 |
Insmed Incorporated |
Methods of treating pulmonary disorders with liposomal amikacin formulations
|
CA2725012C
(en)
|
2008-05-23 |
2019-05-07 |
National Jewish Health |
Methods for treating injury associated with exposure to an alkylating species
|
US8911711B2
(en)
*
|
2008-09-30 |
2014-12-16 |
The Invention Science Fund I, Llc |
Method, device, and system to control pH in pulmonary tissue of a subject
|
DE102009031274A1
(de)
*
|
2009-06-30 |
2011-01-13 |
Justus-Liebig-Universität Giessen |
Liposomen zur pulmonalen Applikation
|
EP2394640A1
(de)
|
2010-05-21 |
2011-12-14 |
MediGene AG |
Verbesserte liposomale Formulierungen von lipophilen Verbindungen
|
CN104349783B
(zh)
|
2012-05-21 |
2018-07-13 |
英斯麦德公司 |
治疗肺部感染的系统
|
RU2675859C2
(ru)
|
2012-11-29 |
2018-12-25 |
Инсмед Инкорпорейтед |
Стабилизированные составы ванкомицина
|
PT3142643T
(pt)
|
2014-05-15 |
2019-10-28 |
Insmed Inc |
Métodos para o tratamento de infeções mico bacterianas pulmonares não tuberculares
|
RU2017127734A
(ru)
|
2015-01-07 |
2019-02-07 |
Трайджемина, Инк. |
Магнийсодержащие составы окситоцина и способы применения
|
EP3773505A4
(de)
|
2018-03-30 |
2021-12-22 |
Insmed Incorporated |
Verfahren zur kontinuierlichen herstellung von liposomalen arzneimittelprodukten
|
AU2019261329A1
(en)
|
2018-04-23 |
2020-11-12 |
Inspirmed Corp. |
Inhalable liposomal sustained release composition for use in treating pulmonary diseases
|